Bausch + Lomb announced it will present more than 40 scientific papers and posters at the upcoming Association for Research in Vision and Ophthalmology (ARVO) annual meeting, scheduled for May 3–7, 2026, in Denver, Colorado.

The presentations will span the company’s broad portfolio, highlighting new clinical and real-world data across pharmaceuticals, contact lenses, surgical devices and vision care products. Featured brands include Lumify redness reliever eye drops, Blink NutriTears nutritional supplement, Xiidra (lifitegrast ophthalmic solution) 5%, Miebo (perfluorohexyloctane ophthalmic solution), Infuse/Ultra One Day and Biotrue ONEday contact lenses, enVista Envy IOLs and the Stellaris Elite Vision Enhancement System.

In addition to marketed products, Bausch + Lomb will present new findings on pipeline assets, including the enVista Beyond extended depth of focus IOL and investigational therapies targeting glaucoma, neuropathic ocular pain, age-related macular degeneration (AMD) and lens care innovations.\

Below is a complete list of presentations.

Paper Presentations

  • “Effect of Physician Recommendation of AREDS2 Supplements on Structural Biomarkers of AMD Progression.” D. Chen et al.
  • “The Effect of BL1107 on Intraocular Pressure and Visual Function in a Phase 2 Randomized Clinical Trial in Patients With Glaucoma or Ocular Hypertension.” S. Whitcup et al.
  • “Disinfection Efficacy of a New Dual-Disinfectant Investigational Multi-Purpose Solution and Comparator Multi-Purpose Solutions Against Acanthamoeba Trophozoites.” W. Domm et al.

Poster Presentations

  • “Examination of the Effects of Hyaluronic Acid on Cellular Metabolic Activity in Transformed Human Conjunctival and Corneal Epithelial Cells Exposed to Desiccation Stress” K. VanDerMeid et al.
  • “Examination of the Effects of Glycerin on Cellular Metabolic Activity in Transformed Human Conjunctival and Corneal Epithelial Cells Exposed to Desiccation Stress.” J. Russell et al.
  • “Patient-Reported Outcomes of a Supplement in Adults With Dry Eye Disease: A 56-Day In-Home Usage Study.” J. Poteet et al.
  • “Global Unmet Needs in Dry Eye: A Comparative Assessment Across the United States and Five International Populations.” R. Ryan et al.
  • “A Phase 3 Randomized Trial of a Novel Brimonidine Tartrate Ophthalmic Solution With Sodium Hyaluronate.” S. Kannarr et al.
  • “Comparative Analysis of AREDS2 and AREDS2+B Vitamin Complex in an in vitro Model of Age-Related Macular Degeneration.” R. Srinivasagan et al.
  • “Clinical Outcomes and Patient Experience Following IOL Exchange With a Full Visual Range Intraocular Lens.” R. Wong et al.
  • “Outcomes of a Novel Full Visual Range Intraocular Lens in Eyes With Previous Corneal Refractive Surgery.” J. Wong et al.
  • “Visual Outcomes at Different Distances With a Full Visual Range Intraocular Lens, a Case Series Study.” G. Lau et al.
  • “Halo Characterization of Two Extended Range of Vision Intraocular Lenses.” J. Antonio Azor Morón et al.
  • “Optical Evaluation of Halos in Multifocal Intraocular Lenses.” L.Nijm et al.
  • “Optical Quality of Two Refractive Full Range of Vision Intraocular Lenses: Impact of Tilt and Decentration.” F. Vega et al.
  • “Intermediate Vision Outcomes of Monofocal Intraocular Lenses Following Cataract Extraction: A Retrospective Cohort Study.” Schavee P et al.
  • “Impact of IOL Asphericity on Simulated Defocus Curves.” F. Alba-Bueno et al.
  • “Corneal Incision Temperature During Phaco Energy Activation - An ex vivo Comparative Study.” A. Papour et al.
  • “Impact of Flow Rate and Ultrasound Energy on Viscoelastic Erosion in a Model Eye.” G. Higgins et al.
  • “Early Outcomes of Standalone Excimer Laser Trabeculostomy in Open Angle Glaucoma: A Prospective Washout Study.” Patel B et al.
  • “Real-World Characteristics of Autoimmune Patients With Dry Eye Disease Treated With Lifitegrast: Insights From the AAO IRIS® Registry.” C. Koetting et al.
  • “Physician Perspectives on the Clinical Use of Concomitant Perfluorohexyloctane and Lifitegrast in Dry Eye Disease Management: Results From a Nationwide Survey.” F. Mah et al.
  • “BL1312 Significantly Reduces Pain Over 24 Hours Following Photorefractive Keratectomy: A Sum of Pain Intensity Differences Analysis.” L. Rajagopalan et al.
  • “Risk Factors for Contralateral Eye Involvement in Non-Arteritic Anterior Ischemic Optic Neuropathy: A Retrospective Cohort Analysis of Electronic Health Records.” E. Donovan et al.
  • “BL1332, a TRPV1 Antagonist, Reduces Capsaicin-Induced Acute Ocular Pain in a Rat Model.” V Vozella et al.
  • “The Effects of BL1332, a novel TRPV1 Antagonist, on Corneal Wound Healing Rate and Corneal Sensitivity.” L. Christie et al.
  • “A Novel Alpha2-Adrenergic Receptor Agonist, BL1106, has Structural and Functional Benefits in a Blue Light Model of Retinal Degeneration.” C. Harrower et al.
  • “Retinal Bioavailability and Functional Effects of a Deuterium Labelled Very-Long-Chain Polyunsaturated Fatty Acid (VLC-PUFA) in Wild-Type and Transgenic Mice.” J. Bound David et al.
  • “Early Response to Treatment With Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease: A Post Hoc Analysis of Two Randomized Trials.” J. Sheppard
  • “Preoperative and Postoperative Treatment With Perfluorohexyloctane Ophthalmic Solution in Patients Undergoing Cataract Surgery: Effects on Signs and Symptoms of Dry Eye Disease.” E. Liang
  • “Effects of Preoperative Treatment With Perfluorohexyloctane Ophthalmic Solution on Refractive Outcomes in Patients With Dry Eye Disease Undergoing Cataract Surgery.” J. Bacharach
  • “Retrospective Real-World Evidence Study of Clinical Outcomes and Eyecare Practitioner Satisfaction With Topical Latanoprostene Bunod in Patients With Ocular Open-Angle Glaucoma or Ocular Hypertension.” N. Cothran et al.
  • “Durability of Suprachoroidal Triamcinolone Acetonide in Eyes With Chronic Cystoid Macular Edema in Real-World Clinical Practice.” A. Talwar et al.
  • “Suprachoroidal Triamcinolone Acetonide for Macular Edema: Real World Safety and Efficacy Outcomes From a Tertiary Eye Center.” A. Mobasserian et al.
  • “Disinfection Efficacy of Acanthamoeba Trophozoites by Rigid Gas Permeable Contact Lens Care Products.” H. Wheeler et al.
  • “Clinical Evaluation of a New Multi-Purpose Solution for Soft Contact Lens Wearers.” G Wesley et al.
  • “Regimen Evaluation of a Biotrue Hydration Plus Multi-Purpose Solution Against ISO Microbial Organisms.” T. Bassage
  • “Real-World Assessment of a Multi-Purpose Contact Lens Solution in Contact Lens Wearers With Heavy Digital Device Use and Contact Lens-Related Dryness.” J. Tsai et al.
  • “A Meta-Analysis of the Safety of Nesofilcon a Soft Daily Disposable Hydrogel Contact Lenses.” K. Hoffman et al.
  • “Real-World Evaluation of Patient Satisfaction and Experience With a Novel Daily Disposable Toric Contact Lens.” K. Bhagat et al.
  • “New Contact Lens Wearers’ Real-World Experience and Satisfaction With a Novel Daily Disposable Toric Contact Lens.” J. Womack et al.